Oarsman Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-191
Closed -$7.52K 367
2024
Q4
$7.52K Sell
191
-175
-48% -$6.89K ﹤0.01% 722
2024
Q3
$17.2K Buy
+366
New +$17.2K ﹤0.01% 618